Renovation work at the Mikasa Research Institute
First written in FY2020-Q3. 1 of 3 entries say "Advanced", first in FY2020. Latest entry: 2026-09-15.
No other company in this theme has enough history to compare yet.
- 2026-09-15DroppedManagement PlanningSuggests it is closing out
「The Company resolved to close the site after production in May 2027 and consolidate its manufacturing functions at the Maebashi Research Institute in Maebashi, Gunma Prefecture, the service’s other site.」
The Company resolved to end the Mikasa Research Institute’s function as a manufacturing site at the end of May 2027 and consolidate manufacturing at the Maebashi Research Institute. - FY2020AdvancedAnnual report
「In the genetically modified silkworm business, the company renovated the Mikasa Research Institute to increase production capacity for human-type collagen I and III.」
At the Mikasa Research Institute, renovation work was carried out to increase production capacity for human-type collagen I and III, in addition to research into anti-HIV antibodies and other areas. - FY2020-Q3First statedAnnual report
「Selling, general and administrative expenses increased due to higher research and development costs in the genetically modified silkworm business, as renovation work at the Mikasa Research Institute and research into the development of biopharmaceuticals, including anti-HIV antibodies, progressed.」
Renovation work at the Mikasa Research Institute was mentioned for the first time as a factor behind the increase in research and development costs, alongside research into biopharmaceuticals such as anti-HIV antibodies.